Literature DB >> 2648134

Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia.

S J Compere1, P A Baldacci, A H Sharpe, R Jaenisch.   

Abstract

Infection of mouse embryos at 8 days of gestation with a replication-defective retrovirus carrying the human c-Ha-ras-1 oncogene led to efficient and rapid induction of hyperplastic lesions. Twenty-four percent of viable off-spring developed abnormal growths after infection with purified virus. The lesions contained a single integrated provirus and produced viral RNA and the Ha-ras oncogene product (p21). The latency period between the time of infection and appearance of the lesions suggested that secondary alterations in addition to activated ras were necessary for neoplasms to develop. The earliest and most abundant growths were cutaneous and appeared from 4 to 36 weeks of age, with a median of 4 weeks of age. A number of subcutaneous lesions also developed over the same time span but at a median of 18 weeks of age. The rapid development of cutaneous lesions in response to transduction of the ras oncogene contrasts with other studies in which adult skin required secondary treatment with promoters prior to ras induction of epithelial hyperplasia. These results demonstrate that infection of midgestation mouse embryos allows rapid analysis of oncogene potency in skin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648134      PMCID: PMC362139          DOI: 10.1128/mcb.9.1.6-14.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

2.  Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; A P Feinberg
Journal:  Science       Date:  1985-02-08       Impact factor: 47.728

3.  Optimal immunoreactivity of keratin proteins in formalin-fixed, paraffin-embedded tissue requires preliminary trypsinization. An immunoperoxidase study of various tumours using polyclonal and monoclonal antibodies.

Authors:  G S Pinkus; E M O'Connor; C L Etheridge; J M Corson
Journal:  J Histochem Cytochem       Date:  1985-05       Impact factor: 2.479

4.  Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis.

Authors:  M Quintanilla; K Brown; M Ramsden; A Balmain
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

5.  Bovine papillomavirus genome elicits skin tumours in transgenic mice.

Authors:  M Lacey; S Alpert; D Hanahan
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

6.  v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis.

Authors:  K Brown; M Quintanilla; M Ramsden; I B Kerr; S Young; A Balmain
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

7.  Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector.

Authors:  H Stuhlmann; R Cone; R C Mulligan; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Expression of p21 ras oncoproteins in human cancers.

Authors:  T Tanaka; D J Slamon; H Battifora; M J Cline
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

9.  Keratinocytes blocked in phorbol ester-responsive early stage of terminal differentiation by sarcoma viruses.

Authors:  S H Yuspa; A E Kilkenny; J Stanley; U Lichti
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

10.  Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals.

Authors:  S H Yuspa; W Vass; E Scolnick
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

View more
  5 in total

1.  Development of transforming function during transduction of proto-ras into Harvey sarcoma virus.

Authors:  M Lang; I Treinies; P H Duesberg; R Kurth; K Cichutek
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

2.  Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?

Authors:  M Corominas; H Kamino; J Leon; A Pellicer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

3.  Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri.

Authors:  J U Jung; J J Trimble; N W King; B Biesinger; B W Fleckenstein; R C Desrosiers
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors.

Authors:  S J Compere; P Baldacci; A H Sharpe; T Thompson; H Land; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target.

Authors:  C A Hall-Jackson; T Jones; N G Eccles; T P Dawson; J A Bond; A Gescher; D Wynford-Thomas
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.